New York, New York (PRWEB) September 19, 2013
Actos lawsuits (http://www.consumerinjurylawyers.com/actos/Actos-Lawsuit.html) continue to move forward in courts throughout the country, Bernstein Liebhard LLP reports. According to an Order issued on August 26th, the federal judge overseeing thousands of claims in the Actos bladder cancer litigation underway in U.S. District Court, Western District of Louisiana, has scheduled the proceeding’s Status Conferences through December 2014. The litigation’s next conference is to be convened on September 26th at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)
“We hear from alleged victims of Actos bladder cancer on a regular basis. We are pleased to see this litigation progressing, and look forward to its first trials next year,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is currently offering free Actos lawsuit evaluations to individuals who were diagnosed with bladder cancer following long-term use of the drug.
Actos Bladder Cancer Lawsuits
According to court documents, at least 2,500 Actos lawsuits involving bladder cancer allegations have been filed in the litigation underway in Louisiana. All of the lawsuits allege that Takeda Pharmaceuticals and other defendants concealed their knowledge of the bladder cancer risk associated with Actos, and failed to provide adequate warnings to the public and medical community. The litigation’s first Actos bladder cancer lawsuit will go to trial on January 27, 2014, while its second Actos bladder cancer trial will commence on April 14, 2014.
While the trials have yet to begin in the federal Actos litigation, court documents indicate that that some cases have gone before juries at the state level. In fact, the nation’s second trial of an Actos bladder cancer claim is currently underway in Maryland State Court. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.) In April, the nation’s first trial involving Actos bladder cancer allegations ended with a Los Angeles Superior Court jury awarding $6.5 million to a plaintiff who was diagnosed with the disease after taking Actos for four years. However, the judge overseeing the case granted Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Actos lawsuits began to mount in courts throughout the country shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that long-term use of the drug could increase the risk of developing bladder cancer. According to Bloomberg.com, Actos was also pulled from the market in Germany and France that month because of its association with bladder cancer.*
Alleged victims of Actos bladder cancer bladder cancer may be entitled to compensation for medical bills, lost wages and other damages related to their illness. Learn More about filing an Actos lawsuit by visiting Bernstein Liebhard LLP’s website. For additional information, please contact Bernstein Liebhard LLP today by calling 800-511-5092.
*bloomberg.com/news/2013-09-04/takeda-put-actos-sales-ahead-of-consumer-safety-lawyer-says-1-.html, Bloomberg.com, September 4, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP